Scott Schoenhaus Analyst PerformanceEquity Research at KeyCorpScott Schoenhaus is a stock analyst at KeyCorp focused in the healthcare sector, covering 23 publicly traded companies. Over the past year, Scott Schoenhaus has issued 38 stock ratings, including buy and hold recommendations. While full access to Scott Schoenhaus' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Scott Schoenhaus' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings60 Last 6 YearsBuy Recommendations86.21% 50 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution58RatingsDistribution of strong buy, buy, hold, and sell ratings by Scott Schoenhaus.RatingPercentageCount Strong Buy0.0%0 ratings Buy86.2%50 ratings Hold13.8%8 ratings Sell0.0%0 ratingsOut of 58 total stock ratings issued by Scott Schoenhaus at KeyCorp, the majority (86.2%) have been Buy recommendations, followed by 13.8% Hold.Best & Worst CallsBest Call000.0%HNGEJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ODDApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ60.9% of companies on NASDAQ14 companiesNYSE39.1% of companies on NYSE9 companiesScott Schoenhaus, an analyst at KeyCorp, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare19 companies82.6%Materials2 companies8.7%Consumer Staples1 company4.3%Industrials1 company4.3%Scott Schoenhaus of KeyCorp specializes in stock coverage within the Healthcare sector, with additional focus on Materials and Consumer Staples companies.Coverage IndustriesIndustryPercentageHEALTHCARE TECHNOLOGY8 companies34.8%HEALTHCARE PROVIDERS & SERVICES7 companies30.4%CHEMICALS2 companies8.7%BIOTECHNOLOGY2 companies8.7%HEALTHCARE EQUIPMENT & SUPPLIES1 company4.3%PERSONAL CARE PRODUCTS1 company4.3%PROFESSIONAL SERVICES1 company4.3%LIFE SCIENCES TOOLS & SERVICES1 company4.3% About Scott SchoenhausScott Schoenhaus is a Managing Director and Equity Research Analyst for KeyBanc Capital Markets Inc. With the firm since May 2022, he focuses on researching healthcare IT (HCIT) companies. Prior to joining KeyBanc Capital Markets, Scott had been at Stephens Inc. for eight years, where he most recently served as a Managing Director and Senior Analyst on HCIT research coverage. Scott started his career in equity research as an Industrials Research Associate at Wolfe Research (airlines, freight & transportation) in 2011. In total, Scott has 15 years of experience in the financial industry, which includes work experience at Sanford Bernstein and Mezz Cap. Scott earned an Bachelor’s degree in economics from Georgetown University. He also holds the Series 7, 63, 86 & 87 industry licenses.Follow on LinkedIn Scott Schoenhaus' Ratings History at KeyCorp Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsOMCLOmnicell8/24/2026Reiterated Rating$35.29Overweight$0.0000.00% ROILFMDLifeMD8/7/2026Set Price Target$3.44$5.00Overweight$0.0000.00% ROIWAYWaystar7/31/2026Reiterated Rating$21.34Overweight$0.0000.00% ROIOMCLOmnicell7/31/2026Lower Price Target$37.11$65.00Overweight$0.0000.00% ROIPGNYProgyny7/13/2026Boost Price Target$30.65$35.00Overweight$0.0000.00% ROIHNGEHinge Health7/13/2026Boost Price Target$88.63$125.00Overweight$0.0000.00% ROIWAYWaystar7/1/2026Initiated Coverage$21.43$30.00Overweight$0.0000.00% ROIWAYWaystar7/1/2026Initiated Coverage$23.46$30.00Overweight$0.0000.00% ROIHNGEHinge Health6/12/2026Boost Price Target$64.60$90.00Overweight$0.0000.00% ROIODDODDITY Tech6/3/2026Reiterated Rating$9.84Sector Weight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. OMCLOmnicell4/28/2026Boost Price Target$44.41$70.00Overweight$0.0000.00% ROIPGNYProgyny3/2/2026Lower Price Target$18.07$28.00Overweight$0.0000.00% ROIODDODDITY Tech2/26/2026Lower Price Target$13.80$30.00Overweight$0.0000.00% ROILFSTLifeStance Health Group2/26/2026Boost Price Target$7.00$9.00Overweight$0.0000.00% ROIODDODDITY Tech2/20/2026Reiterated Rating$32.01Overweight$0.0000.00% ROIALITAlight2/19/2026Downgrade$0.90Sector Weight$0.0000.00% ROITHCTenet Healthcare2/12/2026Boost Price Target$225.86$250.00Overweight$0.0000.00% ROIHNGEHinge Health2/11/2026Set Price Target$37.65$55.00$0.0000.00% ROIDOCSDoximity2/6/2026Set Price Target$27.32$38.00$0.0000.00% ROITALKTalkspace1/8/2026Boost Price Target$3.96$5.00Overweight$0.0000.00% ROIPGNYProgyny1/8/2026Boost Price Target$26.80$32.00Overweight$0.0000.00% ROIHQYHealthEquity1/8/2026Boost Price Target$97.77$125.00Overweight$0.0000.00% ROIHNGEHinge Health1/8/2026Lower Price Target$49.06$70.00Overweight$0.0000.00% ROIDOCSDoximity1/8/2026Lower Price Target$46.50$60.00Overweight$0.0000.00% ROIODDODDITY Tech1/8/2026Lower Price Target$38.00$50.00Overweight$0.0000.00% ROICERTCertara1/8/2026Lower Price Target$9.49$12.00Overweight$0.0000.00% ROIALITAlight1/8/2026Lower Price Target$35.24$50.00Overweight$0.0000.00% ROISDGRSchrodinger1/8/2026Lower Price Target$18.34$25.00Overweight$0.0000.00% ROIOMCLOmnicell1/7/2026Upgrade$47.45$60.00Overweight$0.0000.00% ROIVEEVVeeva Systems12/12/2025Reiterated Rating$229.38Sector Weight$0.0000.00% ROIPGNYProgyny11/11/2025Upgrade$23.81$30.00Overweight$0.0000.00% ROISLPSimulations Plus10/29/2025Reiterated Rating$18.30Sector Weight$0.0000.00% ROIHQYHealthEquity10/8/2025Lower Price Target$88.50$120.00Overweight$0.0000.00% ROIHCATHealth Catalyst10/8/2025Lower Price Target$2.85$4.00Overweight$0.0000.00% ROIDOCSDoximity10/8/2025Boost Price Target$71.37$80.00Overweight$0.0000.00% ROICERTCertara10/8/2025Boost Price Target$12.93$16.00Overweight$0.0000.00% ROISDGRSchrodinger10/8/2025Lower Price Target$20.16$28.00Overweight$0.0000.00% ROIODDODDITY Tech10/8/2025Lower Price Target$59.40$80.00Overweight$0.0000.00% ROILFMDLifeMD8/6/2025Lower Price Target$6.79$12.00Overweight$0.0000.00% ROIALBAlbemarle7/30/2025Reiterated Rating$71.63Sector Weight$000.0000.00% ROITrump's New Dollar (Ad)Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.Watch the free briefing and see the three steps to prepare todaySLPSimulations Plus7/15/2025Downgrade$17.47Sector Weight$00.0000.00% ROICERTCertara7/14/2025Lower Price Target$11.09$15.00Overweight$0.0000.00% ROIALBAlbemarle7/14/2025Lower Price Target$71.07$87.00Overweight$000.0000.00% ROIABCLAbCellera Biologics7/14/2025Boost Price Target$4.01$10.00Overweight$0.0000.00% ROIEMNEastman Chemical7/14/2025Lower Price Target$80.29$93.00Overweight$00.0000.00% ROIDOCSDoximity7/14/2025Boost Price Target$60.26$70.00Overweight$00.0000.00% ROISLPSimulations Plus7/14/2025Downgrade$16.96$25.00Sector Weight$00.0000.00% ROIHNGEHinge Health6/16/2025Initiated Coverage$34.76$45.00Overweight$00.0000.00% ROIODDODDITY Tech4/16/2025Lower Price Target$41.08$50.00Overweight$00.0000.00% ROIHQYHealthEquity4/16/2025Lower Price Target$83.03$100.00Overweight$00.0000.00% ROICERTCertara4/16/2025Boost Price Target$13.88$18.00Overweight$0.0000.00% ROIABSIAbsci4/16/2025Boost Price Target$3.12$9.00Overweight$0.0000.00% ROIABCLAbCellera Biologics4/16/2025Boost Price Target$2.43$5.00Overweight$0.0000.00% ROISLPSimulations Plus4/16/2025Boost Price Target$32.81$40.00Overweight$00.0000.00% ROISDGRSchrodinger4/16/2025Boost Price Target$25.59$32.00Overweight$00.0000.00% ROIPHRPhreesia4/16/2025Lower Price Target$23.89$28.00Overweight$0.0000.00% ROIHQYHealthEquity3/24/2025Lower Price Target$84.88$110.00Overweight$00.0000.00% ROISDGRSchrodinger1/24/2025Boost Price Target$24.91$27.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
